Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 11, 2020 16:01 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics to Announce First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 13

TUCSON, Ariz., May 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will...
March 25, 2020 16:01 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Reports Full Year 2019 Results

Increased product and product-related services revenue over prior year, benefitting from expanded menu of profiling assays and increased number of customers adopting technology Released new...
March 17, 2020 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics to Announce Year End 2019 Financial Results and Host Conference Call on Wednesday, March 25

TUCSON, Ariz., March 17, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will...
February 19, 2020 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conference

TUCSON, Ariz., Feb. 19, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that...
February 11, 2020 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG EdgeSeq Mouse mRNA Tumor Response Panel Used by Researchers Targeting Cardiac Fibrosis with Engineered T-cells

TUCSON, Ariz., Feb. 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the...
February 05, 2020 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG EdgeSeq miRNA Whole Transcriptome Assay is Highly Reproducible in Biofluids for Potential Use as a Biomarker

TUCSON, Ariz., Feb. 05, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the...
January 28, 2020 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Receives European Patent Grant Notification for Methods for Subtyping Diffuse Large B-cell Lymphoma

TUCSON, Ariz., Jan. 28, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has...
January 13, 2020 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Announces Preliminary 2019 Unaudited Financial Results

Preliminary full year 2019 unaudited revenue of $19.2 million Cash and cash equivalents of $33.0 million as of December 31, 2019 TUCSON, Ariz., Jan. 13, 2020 (GLOBE NEWSWIRE) -- HTG Molecular...
December 03, 2019 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics to Host Key Opinion Leader Meeting on the Future of Precision Medicine

TUCSON, Ariz., Dec. 03, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it...
November 19, 2019 08:00 ET | Source: HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics Expands Analytics Capabilities with Release of New Software Update

TUCSON, Ariz., Nov. 19, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, yesterday announced the...